Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News DarioHealth Corp DRIO

Healthcare Medical Devices
DarioHealth Corp. is a global digital therapeutics (DTx) company. The Company operates at the intersection of life sciences, behavioral science, and software technology to deliver seamlessly integrated and highly engaging digital therapeutic interventions. Its platform and suite of solutions delivers personalized and dynamic interventions driven by data analytics and one-on-one coaching for... see more

Recent & Breaking News (NDAQ:DRIO)

DarioHealth to Report Fourth Quarter and Full Year 2021 Results on Monday, March 21

PR Newswire March 14, 2022

DarioHealth Announces Two New Contracts within the Employer and Provider Market

PR Newswire March 9, 2022

DarioHealth to Participate in the Cowen 42nd Annual Healthcare Conference

PR Newswire March 7, 2022

DarioHealth Enters into Strategic Agreement with Sanofi U.S.

PR Newswire March 1, 2022

DarioHealth Announced Pricing of its Registered Direct Offering for Aggregate Proceeds of $40 Million Priced At-The-Market Under Nasdaq Rules

PR Newswire March 1, 2022

DarioHealth Publishes Clinical Outcomes Demonstrating the Impact of Using a Single Digital Therapeutics Platform for Multiple Conditions

PR Newswire February 9, 2022

DarioHealth Announces Four New Employer Contracts

PR Newswire February 8, 2022

DarioHealth Enters Agreement to Acquire Physimax, a Leading Provider of Validated Computer Vision for Musculoskeletal Health

PR Newswire January 20, 2022

DarioHealth Enters into Agreement with Large Regional Health Plan

PR Newswire January 19, 2022

DarioHealth to Host Investor Webinar on Navigating Emerging Digital Health Trends for Strategic Growth in 2022

PR Newswire January 18, 2022

DarioHealth Announces Two New Contracts within the Employer Market

PR Newswire January 6, 2022

DarioHealth Selected as Exclusive Digital Therapeutics Provider to a Leading Benefits Brokerage

PR Newswire December 21, 2021

DarioHealth Announces Two New Contracts within the Employer and Provider Markets

PR Newswire December 2, 2021

DarioHealth Announces Two New Employer Contracts

PR Newswire November 18, 2021

DarioHealth Reports Third Quarter 2021 Results and Operational Highlights

PR Newswire November 15, 2021

DarioHealth Appoints Seasoned Health Care Executive Jerrod Helms as Chief Commercial Officer

PR Newswire November 15, 2021

DarioHealth Announces Three New Contracts as Growth Continues to Accelerate Across the Employer and Provider Markets

PR Newswire November 11, 2021

DarioHealth to Report Third Quarter 2021 Results on Monday, November 15

PR Newswire November 8, 2021

DarioHealth to Participate in Upcoming Investor Conferences

PR Newswire November 5, 2021

DarioHealth Partners with National Group Benefits Platform

PR Newswire November 3, 2021